Source comparison
AOD-9604 vs Other Fat Loss Peptides: Honest Comparison
Where does AOD-9604 sit in the landscape of peptide-based fat loss? Below is a comparison using available clinical evidence. The table reveals why AOD-9604 occupies a specific niche rather than competing directly with GLP-1 agonists. AOD-9604 Direct lipolysis,
This comparison does not assign a generated winner or score.
- Where does AOD-9604 sit in the landscape of peptide-based fat loss? Below is a comparison using available clinical evidence. The table reveals why AOD-9604 occupies a specific niche rather than competing directly with GLP-1 agonists.
- AOD-9604
- Direct lipolysis, lipogenesis inhibition
- ~2-3 kg (12 wk)
- Phase 2 only
- Minimal
- None
- Semaglutide 2.4 mg
- GLP-1 appetite suppression
- ~12.4 kg (68 wk)
- Phase 3 (STEP)
- GI: 44% nausea
- Strong
- Tirzepatide 15 mg
- GLP-1/GIP dual agonist
- ~20.2 kg (72 wk)
- Phase 3 (SURMOUNT)
- GI: 31% nausea
- Retatrutide 12 mg
- GLP-1/GIP/glucagon triple
- ~24.2 kg (48 wk)
- Phase 3 (TRIUMPH)
- GI + dysesthesia
- Very strong
- HGH Fragment 176-191
- Direct lipolysis
- No human trial data
- Animal only
- MOTS-c
- Mitochondrial, AMPK
- Limited human data
- Phase 1/2
- Indirect
- The comparison is stark. GLP-1 agonists produce 5-10 times more weight loss because they create massive caloric deficits through appetite suppression and gastric slowing. AOD-9604 does not touch appetite. It works at the fat cell level, mobilizing stored triglycerides without changing how much you eat.
- This does not make AOD-9604 useless. It makes it appropriate for a different use case: the person who already controls their diet, exercises consistently, and wants a modest additional push in fat mobilization without the gastrointestinal side effects, nausea, or hormonal disruption that come with GLP-1 agonists. If you want dramatic weight loss, AOD-9604 is not the compound. If you want a clean fat-loss enhancer with virtually no side effects, it has a rational place in the toolkit.
- For detailed information on the GLP-1 comparison, see how does retatrutide work and retatrutide vs tirzepatide. For MOTS-c dosing details, see our MOTS-c dosage guide.